Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Nihonbashi Life Science Building 7, 9-10, 1 cho-me, Chuo-ku, Tokyo, , 103-0012, JP
PeptiGrowth, a joint venture between PeptiDream and Mitsubishi Corporation, is focused on the invention of innovative peptide compounds for use in cell culture media. Based in Tokyo, PeptiGrowth was created in 2020 to address challenges in regenerative medicine and cell therapy research, particularly the issues surrounding the use of recombinant protein growth factors, such as […]
Released By PeptiGrowth
The companies will use Cellular Origins’ automated mobile robotic platform.
By: Patrick Lavery
The partnership allows the Butantan Institute to expand its portfolio of advanced therapies.
By: Charlie Sternberg
Provides an automated, functionally closed approach to help streamline cell therapy manufacturing.
By: Kristin Brooks
Will establish a commercial cell therapy manufacturing and supply base, enabling end-to-end cell therapy capabilities in China.
New perfusion‑based adherent cell‑culture bioreactor is designed to scale cell therapy manufacturing with integrated process monitoring and automated harvesting.
New integrated system is designed to address structural manufacturing bottlenecks that limit scalability and patient access to transformative treatments.
GelMEDIX gains access to Catalent’s proprietary, off-the-shelf, GMP-compliant iPSC lines and Catalent’s GMP iPSC and iPSC-derived cell therapy manufacturing capabilities.
Will support more than 500 skilled biomanufacturing jobs when fully operational and more than 4,000 construction jobs during site development.
The closure is part of an ongoing restructuring at the Boston-based contract research organization
Explores new applications of its long-established microbubble technology.
Funding aims to enable global commercial launch and supply of cell therapies.
To evaluate the potential for applying GMP-ready robotic systems to commercial-scale cell therapy manufacturing.
Dr. David Townson offers a proven track record of advancing transformative oncology and cell therapy programs.
The certification highlights the company’s adherence to rigorous safety and traceability protocols within the cell and gene therapy supply chain.
To combine TruCytes Biomarker Controls with the Cell Q platform to enhance quality and automation.
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
